Show simple item record

dc.contributor.author Castinetti F,
dc.contributor.author Qi XP,
dc.contributor.author Walz MK,
dc.contributor.author Maia AL,
dc.contributor.author Sanso G,
dc.contributor.author Patócs, Attila Balázs
dc.contributor.author Rácz, Károly
dc.date.accessioned 2015-01-09T21:53:30Z
dc.date.available 2015-01-09T21:53:30Z
dc.date.issued 2014
dc.identifier 84899970790
dc.identifier.citation pagination=648-655; journalVolume=15; journalIssueNumber=6; journalTitle=LANCET ONCOLOGY;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/993
dc.identifier.uri doi:10.1016/S1470-2045(14)70154-8
dc.description.abstract BACKGROUND: The prevention of medullary thyroid cancer in patients with multiple endocrine neoplasia type 2 syndrome has demonstrated the ability of molecular diagnosis and prophylactic surgery to improve patient outcomes. However, the other major neoplasia associated with multiple endocrine neoplasia type 2, phaeochromocytoma, is not as well characterised in terms of occurrence and treatment outcomes. In this study, we aimed to systematically characterise the outcomes of management of phaeochromocytoma associated with multiple endocrine neoplasia type 2. METHODS: This multinational observational retrospective population-based study compiled data on patients with multiple endocrine neoplasia type 2 from 30 academic medical centres across Europe, the Americas, and Asia. Patients were included if they were carriers of germline pathogenic mutations of the RET gene, or were first-degree relatives with histologically proven medullary thyroid cancer and phaeochromocytoma. We gathered clinical information about patients'RET genotype, type of treatment for phaeochromocytoma (ie, unilateral or bilateral operations as adrenalectomy or adrenal-sparing surgery, and as open or endoscopic operations), and postoperative outcomes (adrenal function, malignancy, and death). The type of surgery was decided by each investigator and the timing of surgery was patient driven. The primary aim of our analysis was to compare disease-free survival after either adrenal-sparing surgery or adrenalectomy. FINDINGS: 1210 patients with multiple endocrine neoplasia type 2 were included in our database, 563 of whom had phaeochromocytoma. Treatment was adrenalectomy in 438 (79%) of 552 operated patients, and adrenal-sparing surgery in 114 (21%). Phaeochromocytoma recurrence occurred in four (3%) of 153 of the operated glands after adrenal-sparing surgery after 6-13 years, compared with 11 (2%) of 717 glands operated by adrenalectomy (p=0.57). Postoperative adrenal insufficiency or steroid dependency developed in 292 (86%) of 339 patients with bilateral phaeochromocytoma who underwent surgery. However, 47 (57%) of 82 patients with bilateral phaeochromocytoma who underwent adrenal-sparing surgery did not become steroid dependent. INTERPRETATION: The treatment of multiple endocrine neoplasia type 2-related phaeochromocytoma continues to rely on adrenalectomies with their associated Addisonian-like complications and consequent lifelong dependency on steroids. Adrenal-sparing surgery, a highly successful treatment option in experienced centres, should be the surgical approach of choice to reduce these complications. FUNDING: European Union, German Cancer Foundation, Arthur Blank Foundation, Italian Government, Charles University, Czech Ministry of Health, Nanjing Military Command, National Science Centre Poland, National Research Council for Scientific and Technological Development, and State of Sao Paulo Research Foundation.
dc.relation.ispartof urn:issn:1470-2045
dc.title Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study
dc.type Journal Article
dc.date.updated 2015-01-09T20:13:19Z
dc.language.rfc3066 en
dc.identifier.mtmt 2589832
dc.identifier.wos 000335512100052
dc.identifier.pubmed 24745698
dc.contributor.department SE/ÁOK/K/IISZBK/MTA-SE Lendület Örökletes Endokrin Daganatok Kutatócsoport
dc.contributor.department SE/ÁOK/K/II. Sz. Belgyógyászati Klinika
dc.contributor.institution Semmelweis Egyetem


Files in this item

xmlui.dri2xhtml.METS-1.0.onlyFromAllowedIP

View/Open

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account